Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Postmarketing Trial For Horizon Thyroid Eye Drug Tepezza To Be Larger Than Expected
Jan 22 2020
•
By
Derrick Gingery
As part of its postmarketing requirements, Horizon must also complete the ongoing OPTIC-X trial, which is expected later this year. • Source: Shutterstock
More from Post-Marketing Regulation & Studies
More from Product Reviews